30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom Biotechnology & Medical Research

OptiBiotix Health PLC (OPTI)

Track

Over the last 90 days, OptiBiotix Health PLC saw one insider transaction, a buy totaling £9,808.14 by the Finance Director. This single executive purchase represents a net buy of 0.0017% of the float. Prior to this, several other executives and directors made smaller buy transactions.
Stock chart
Ticker: OPTI Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
David Blain
Finance Director
1 purchase — total 9,808 GBP
Buy 28 May 2026
Value £1,277,023.62 | Price 213.74 | Shares 92,263
Buy 31 Aug 2021
Value £4,468,351.87 | Price 232.77 | Shares 43,697
Buy 26 Aug 2021
Value £13,500.00 | Price 0.54 | Shares 25,000
Buy 20 Apr 2021
Value £18,340.00 | Price 0.52 | Shares 35,000
Buy 20 Apr 2021
Value £25,364.21 | Price 0.53 | Shares 47,857
Buy 15 Apr 2021
Value £12,950.00 | Price 0.52 | Shares 25,000
Buy 12 Mar 2020
Value £10,118.09 | Price 0.39 | Shares 25,700
Buy 28 Aug 2019
Value £8,500.00 | Price 0.50 | Shares 17,000
Buy 29 May 2019
Value £10,680.00 | Price 0.89 | Shares 12,000
Buy 30 Jul 2018
Value £101,558.00 | Price 0.99 | Shares 103,000
Buy 11 Jul 2018
Value £149,100.00 | Price 0.71 | Shares 210,000
Buy 1 Feb 2018
Value £99,000.00 | Price 0.60 | Shares 165,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-29 2026-05-28 B Purchase
David Blain

Finance Director

Executive Director
92,263
213.74
£1,277,024 		92,263 213.74 £1,277,024
2021-09-01 2021-08-31 B Purchase René Kamminga

PDMR
43,697
232.77
£4,468,352 		43,697 232.77 £4,468,352
2021-08-31 2021-08-26 B Purchase Stephen Hammond

Non-Executive Director

Executive Director
12,407
378.77
£3,388,049 		12,407 378.77 £3,388,049
2021-04-21 2021-04-20 B Purchase René Kamminga

PDMR
35,000
0.52
£18,340 		35,000 0.52 £18,340
2021-04-21 2021-04-20 B Purchase Stephen O'Hara

Chief Executive Officer

Officer
47,857
0.53
£25,364 		47,857 0.53 £25,364
2021-04-16 2021-04-15 B Purchase Stephen Hammond

Non-Executive Director

Executive Director
25,000
0.52
£12,950 		25,000 0.52 £12,950
2020-03-16 2020-03-12 B Purchase Frédéric André Narbel

Director

Executive Director
25,700
0.39
£10,118 		25,700 0.39 £10,118
2019-08-28 2019-08-28 B Purchase Frédéric André Narbel

Director

Executive Director
17,000
0.50
£8,500 		17,000 0.50 £8,500
2019-05-29 2019-05-29 B Purchase Frédéric André Narbel

Director

Executive Director
12,000
0.89
£10,680 		12,000 0.89 £10,680
2018-07-31 2018-07-30 B Purchase Neil Davidson

Non-Executive Chairman

Director
103,000
0.99
£101,558 		103,000 0.99 £101,558
2018-07-12 2018-07-11 B Purchase Neil Davidson

Non-Executive Chairman

Director
210,000
0.71
£149,100 		210,000 0.71 £149,100
2018-02-01 2018-02-01 B Purchase Neil Davidson

Non-Executive Chairman

Director
165,000
0.60
£99,000 		165,000 0.60 £99,000
Explore more

More insider trading research around OptiBiotix Health PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe